Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression
Si-Tien Wang,1 Ian M Anderson,2 Dominic Mitchell,3 Scott J Johnson,1 Aki Shiozawa4,5 1Medicus Economics, LLC, Boston, MA, USA; 2Neuroscience and Psychiatry luau thank you cards Unit, University of Manchester and Manchester Academic Health Science Centre, Manchester, UK; 3Medicus Economics, LLC, Repentigny, QC, copyright; 4Department of Health Polic